ADME 101: DMPK and ADME in Drug Development

Originally aired: Oct. 2019
Presenter: Joanna Barbara, Ph.D., Vice President of Scientific Operations at XenoTech
We are pleased to present XenoTech’s first ADME 101 series webinar, Acronyms Abound: DMPK and ADME in Drug Development. ADME 101 is a comprehensive new collection of educational short videos to serve as a resource for researchers and industry professionals to navigate ADME, DMPK, and DDI within the complex landscape of drug development. As we continue to update and add to our repository of resources, we welcome questions and requests for topics our experts may address in future presentations. Please use our online forms to request a topic or get in touch with our team.
Key concepts discussed in this webinar will include:
The overarching aim of therapeutic drug development
DMPK - Drug metabolism and pharmacokinetics
- Based on ADME properties
- Relationship to Drug-Drug Interactions (DDI)
ADME properties
A hint of DDI
Download a copy of the slides: www.xenotech.com/access-adme-...
Questions, comments and requests: www.xenotech.com/contact-us
More information on our research services and test systems: www.xenotech.com
Other previously aired webinars: www.xenotech.com/scientific-r...
Upcoming webinar notifications: www.xenotech.com/newsletter-s...
Request a webinar topic: www.xenotech.com/scientific-r...
About the presenter: Joanna Barbara currently serves as Vice President of Scientific Operations at XenoTech. Joanna obtained her Ph.D. in Analytical Chemistry from the University of Florida. She joined XenoTech in 2007. In that time, Joanna has served in Mass Spectrometry Specialist roles, as the Division Director of Analytical Services and Division Director of Scientific Operations at XenoTech. Dr. Barbara also serves as an Adjunct Graduate Professor of Pharmaceutical Sciences for the College of Pharmacy at the University of Missouri - Kansas City. She has authored or coauthored numerous scientific posters and papers, and has represented XenoTech as an invited speaker at various analytical and drug metabolism conferences. Joanna is quality-oriented with extensive experience in DMPK, regulatory compliance and process and project management. As Vice President of Scientific Operations, Dr. Barbara is responsible for the development, design, operation, and improvement of XenoTech's Scientific Division.